Shandong Sito Bio-technology Co., Ltd. (SHE:300583)
China · Delayed Price · Currency is CNY 12.28
+0.05 (0.41%)
Aug 4, 2026, 3:04 PM CST
SHE:300583 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,085 | 1,017 | 970.6 | 1,280 | 1,312 | 1,203 |
Revenue Growth | 10.04% | 4.77% | -24.16% | -2.46% | 9.10% | 31.70% |
Gross Profit Gross Profit Growth | 165.41 | 116.21 | 108.1 | 268.31 | 261.44 | 246.07 |
Operating Income Operating Income Growth | -8.12 | -39.97 | -88.92 | 61.84 | 72.64 | 62.78 |
Net Income Net Income Growth | -42.02 | -73.15 | -88.77 | 45.6 | 41.97 | 36.21 |
Earnings Per Share EPS Growth | -0.22 | -0.39 | -0.47 | 0.25 | 0.24 | 0.21 |
EPS Growth | - | - | - | 4.17% | 12.94% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 973.52 | 918.22 | 1,225 | 1,242 | 1,167 |
Unallocated Other Unallocated Other Growth | 43.35 | 52.38 | 54.57 | 70.11 | 35.66 |
Total Total Growth | 1,017 | 970.6 | 1,280 | 1,312 | 1,203 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 237.23 | 295.07 | 255.96 | 238.49 | 188.4 | 161.5 |
Total Debt Total Debt Growth | 776.52 | 803.17 | 777.68 | 845.81 | 750.35 | 688.5 |
Net Cash (Debt) Net Cash Growth | -539.29 | -508.1 | -521.72 | -607.32 | -561.95 | -527 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.89 | -2.71 | -2.76 | -3.33 | -3.21 | -3.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 199.55 | 158.53 | 194.46 | -92.85 | 145.34 | 227.35 |
Capital Expenditures CapEx Growth | -95.12 | -79.65 | -65.53 | -94.06 | -143.68 | -388.92 |
Free Cash Flow Free Cash Flow Growth | 104.43 | 78.88 | 128.93 | -186.9 | 1.66 | -161.57 |
Free Cash Flow Growth | 5.65% | -38.82% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 15.24% | 11.43% | 11.14% | 20.96% | 19.93% | 20.46% |
Operating Margin | -0.75% | -3.93% | -9.16% | 4.83% | 5.54% | 5.22% |
Pretax Margin | -3.76% | -7.58% | -10.59% | 4.18% | 3.65% | 4.51% |
Profit Margin | -3.87% | -7.19% | -9.15% | 3.56% | 3.20% | 3.01% |
FCF Margin | 9.62% | 7.76% | 13.28% | -14.60% | 0.13% | -13.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.015 | 0.015 | 0.010 | 0.450 | 0.009 | 0.009 |
Dividend Per Share Growth | -74.70% | 50.64% | -97.78% | 4687.23% | 0% | - |
Dividend Yield | 0.12% | 0.11% | 0.05% | 2.36% | 0.07% | 0.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 82.28 | 58.06 | 73.11 |
Forward PE | - | 70.41 | 70.41 | - | - | - |
P/FCF Ratio | 22.31 | 32.92 | 28.76 | - | 1468.80 | - |
PS Ratio | 2.15 | 2.55 | 3.82 | 2.93 | 1.86 | 2.20 |